Epigral Ltd
Filing rhythm · 60 trading days
23 filings · 8 material · busiest 2026-07-27
What it files
Filings
23 in the window
-
18 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday, 20.08.2026
Company Update / Analyst / Investor Meet View filing →
-
7 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Epigral Limited hereby informs that the officials of the Company are participating in EMKAY Confluence 2026 on 12th August, 2026
Company Update / Analyst / Investor Meet View filing →
-
30 July 2026
Concall TranscriptEarnings Call Transcript
Epigral Limited submits Transcript of Conference Call discussing Q1 FY27 Results.
Company Update / Earnings Call Transcript View filing →
-
30 July 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Epigral Limited informs that the Company is having One-on-One Meeting with Investor / Analyst on Monday, 3rd august, 2026.
Company Update / Analyst / Investor Meet View filing →
-
29 July 2026
Newspaper PublicationNewspaper Publication
Newspaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026
Company Update / Newspaper Publication View filing →
-
29 July 2026
Newspaper PublicationNewspaper Publication
Newpaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026
Company Update / Newspaper Publication View filing →
-
27 July 2026
ResultsUNAUDITED FINANCIAL RESULTS - 30.06.2026
UNAUDITED FINANCIAL RESULTS - 30.06.2026.
Result / Financial Results View filing →
-
27 July 2026
Board OutcomeBoard Meeting Outcome for Outcome Of Board Meeting Held On Monday, 27Th July, 2026 And Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The First Quarter Ended 30Th June, 2026.
Outcome of Board Meeting held on Monday, 27th July, 2026 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the First Quarter ended 30th June, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
27 July 2026
GeneralDisclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') - Outcome Of Board Meeting
As part of the Company's strategic growth and expansion initiatives, it proposes to establish a new manufacturing facility for Epoxy Resin and formulations and Multi Purpose Plant at its ....
Company Update / General View filing →
-
27 July 2026
Press ReleasePress Release / Media Release
Press Release of Un-Audited Financual results - Q1FY27.
Company Update / Press Release / Media Release View filing →
-
27 July 2026
Investor PresentationInvestor Presentation
Investor Presentation Q1 FY 27.
Company Update / Investor Presentation View filing →
-
27 July 2026
Analyst / Investor MeetAnalyst / Investor Meet - Outcome
Audio Recording of Conference Call discussing Q1 FY27 Results held on Monday, 27th July, 2026 at 5.00 p.m.
Company Update / Analyst / Investor Meet View filing →
-
22 July 2026
Board MeetingBoard Meeting Intimation for Intimation Of The Board Meeting Of Epigral Limited Scheduled To Be Held On Monday, 27Th July, 2026.
Epigral Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 ,inter alia, to consider and approve Un-audited Financial Results (Standalone ....
Board Meeting / Board Meeting View filing →
-
22 July 2026
ClarificationClarification sought from Epigral Ltd
The Exchange has sought clarification from Epigral Ltd on July 22, 2026, with reference to Movement in Volume. The reply is awaited.
Company Update / Clarification
-
22 July 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Epigral Limited has informed the Exchange about Conference Call on Monday, 27th July, 2026 to discuss Q1 FY27 Results
Company Update / Analyst / Investor Meet View filing →
-
22 July 2026
GeneralEpigral Limited's Reply To Clarification Sought With Reference To Movement In Volume.
Epigral Limited's reply to clarification sought by the Stock Exchange with reference to Movement in Volume.
Company Update / General View filing →
-
14 July 2026
-
9 July 2026
Compliance CertificateCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Epigral Limited submits certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
7 July 2026
AcquisitionAcquisition
Epigral Limited has informed the Exchange about Inc orporation of a Wholly owned Subsidiary namrly "Epigral Advanced Materials Limited".
Company Update / Acquisition View filing →
-
10 June 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on June 16, 2026.
Company Update / Analyst / Investor Meet View filing →
-
9 June 2026
AGM / EGMShareholder Meeting / Postal Ballot-Scrutinizer's Report
Submission of Scrutinizer's Report of 19th AGM held on 08.06.2026.
AGM/EGM / AGM View filing →
-
8 June 2026
AGM / EGMShareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 19th AGM held on 08.06.2026.
AGM/EGM / AGM View filing →
-
3 June 2026
Credit RatingCredit Rating
Epigral Limited submit Review of CRISIL Ratings on the Bank Facilities of Epigral Limited.
Company Update / Credit Rating View filing →